Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

By Yahoo! Finance   |   1 year ago
Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs

The Biden administration's proposal to expand coverage for weight-loss drugs like Ozempic and Mounjaro in government healthcare plans could reduce costs and make the drugs available to more patients by 2026.

Read More

Did you find this insightful?